Literature DB >> 19252095

Sarcomere length dependence of power output is increased after PKA treatment in rat cardiac myocytes.

Laurin M Hanft1, Kerry S McDonald.   

Abstract

The Frank-Starling relationship of the heart yields increased stroke volume with greater end-diastolic volume, and this relationship is steeper after beta-adrenergic stimulation. The underlying basis for the Frank-Starling mechanism involves length-dependent changes in both Ca(2+) sensitivity of myofibrillar force and power output. In this study, we tested the hypothesis that PKA-induced phosphorylation of myofibrillar proteins would increase the length dependence of myofibrillar power output, which would provide a myofibrillar basis to, in part, explain the steeper Frank-Starling relations after beta-adrenergic stimulation. For these experiments, adult rat left ventricles were mechanically disrupted, permeabilized cardiac myocyte preparations were attached between a force transducer and position motor, and the length dependence of loaded shortening and power output were measured before and after treatment with PKA. PKA increased the phosphorylation of myosin binding protein C and cardiac troponin I, as assessed by autoradiography. In terms of myocyte mechanics, PKA decreased the Ca(2+) sensitivity of force and increased loaded shortening and power output at all relative loads when the myocyte preparations were at long sarcomere length ( approximately 2.30 mum). PKA had less of an effect on loaded shortening and power output at short sarcomere length ( approximately 2.0 mum). These changes resulted in a greater length dependence of myocyte power output after PKA treatment; peak normalized power output increased approximately 20% with length before PKA and approximately 40% after PKA. These results suggest that PKA-induced phosphorylation of myofibrillar proteins explains, in part, the steeper ventricular function curves (i.e., Frank-Starling relationship) after beta-adrenergic stimulation of the left ventricle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252095      PMCID: PMC2685326          DOI: 10.1152/ajpheart.00864.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C.

Authors:  F Steven Korte; Kerry S McDonald; Samantha P Harris; Richard L Moss
Journal:  Circ Res       Date:  2003-09-18       Impact factor: 17.367

Review 2.  Length-dependent Ca(2+) activation in cardiac muscle: some remaining questions.

Authors:  Franklin Fuchs; Donald A Martyn
Journal:  J Muscle Res Cell Motil       Date:  2005-10-05       Impact factor: 2.698

3.  Filament compliance effects can explain tension overshoots during force development.

Authors:  Kenneth S Campbell
Journal:  Biophys J       Date:  2006-09-01       Impact factor: 4.033

4.  Sarcomere length dependence of the rate of tension redevelopment and submaximal tension in rat and rabbit skinned skeletal muscle fibres.

Authors:  K S McDonald; M R Wolff; R L Moss
Journal:  J Physiol       Date:  1997-06-15       Impact factor: 5.182

5.  Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels.

Authors:  C Holubarsch; T Ruf; D J Goldstein; R C Ashton; W Nickl; B Pieske; K Pioch; J Lüdemann; S Wiesner; G Hasenfuss; H Posival; H Just; D Burkhoff
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

6.  Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes.

Authors:  J van der Velden; J W de Jong; V J Owen; P B Burton; G J Stienen
Journal:  Cardiovasc Res       Date:  2000-06       Impact factor: 10.787

7.  Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.

Authors:  Eiki Takimoto; David G Soergel; Paul M L Janssen; Linda B Stull; David A Kass; Anne M Murphy
Journal:  Circ Res       Date:  2004-01-15       Impact factor: 17.367

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner.

Authors:  Norio Fukuda; Yiming Wu; Preetha Nair; Henk L Granzier
Journal:  J Gen Physiol       Date:  2005-03       Impact factor: 4.086

View more
  24 in total

1.  Length dependence of force generation exhibit similarities between rat cardiac myocytes and skeletal muscle fibres.

Authors:  Laurin M Hanft; Kerry S McDonald
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

2.  Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice.

Authors:  Eun-Jeong Lee; Jun Peng; Michael Radke; Michael Gotthardt; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2010-05-23       Impact factor: 5.000

3.  Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.

Authors:  Mohit Kumar; Suresh Govindan; Mengjie Zhang; Ramzi J Khairallah; Jody L Martin; Sakthivel Sadayappan; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

4.  Elevated Ca2+ transients and increased myofibrillar power generation cause cardiac hypercontractility in a model of Noonan syndrome with multiple lentigines.

Authors:  Sarah A Clay; Timothy L Domeier; Laurin M Hanft; Kerry S McDonald; Maike Krenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

5.  The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Julian E Stelzer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

6.  A Novel "Cut and Paste" Method for In Situ Replacement of cMyBP-C Reveals a New Role for cMyBP-C in the Regulation of Contractile Oscillations.

Authors:  Nathaniel C Napierski; Kevin Granger; Paul R Langlais; Hannah R Moran; Joshua Strom; Katia Touma; Samantha P Harris
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

7.  Increased cross-bridge recruitment contributes to transient increase in force generation beyond maximal capacity in human myocardium.

Authors:  Nima Milani-Nejad; Jae-Hoon Chung; Benjamin D Canan; Vadim V Fedorov; Bryan A Whitson; Ahmet Kilic; Peter J Mohler; Paul M L Janssen
Journal:  J Mol Cell Cardiol       Date:  2017-11-12       Impact factor: 5.000

8.  Point mutations in the tri-helix bundle of the M-domain of cardiac myosin binding protein-C influence systolic duration and delay cardiac relaxation.

Authors:  Sabine J van Dijk; Kristina B Kooiker; Nathaniel C Napierski; Katia D Touma; Stacy Mazzalupo; Samantha P Harris
Journal:  J Mol Cell Cardiol       Date:  2018-05-03       Impact factor: 5.000

9.  Calcium sensitivity and myofilament lattice structure in titin N2B KO mice.

Authors:  Eun-Jeong Lee; Joshua Nedrud; Peter Schemmel; Michael Gotthardt; Thomas C Irving; Henk L Granzier
Journal:  Arch Biochem Biophys       Date:  2012-12-14       Impact factor: 4.013

Review 10.  Fibrous scaffolds for building hearts and heart parts.

Authors:  A K Capulli; L A MacQueen; Sean P Sheehy; K K Parker
Journal:  Adv Drug Deliv Rev       Date:  2015-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.